JP2014162761A - 血中ａｐｏＣＩ濃度低下剤 - Google Patents

血中ａｐｏＣＩ濃度低下剤 Download PDF

Info

Publication number
JP2014162761A
JP2014162761A JP2013035845A JP2013035845A JP2014162761A JP 2014162761 A JP2014162761 A JP 2014162761A JP 2013035845 A JP2013035845 A JP 2013035845A JP 2013035845 A JP2013035845 A JP 2013035845A JP 2014162761 A JP2014162761 A JP 2014162761A
Authority
JP
Japan
Prior art keywords
skin
function
apoci
blood
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013035845A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014162761A5 (enExample
Inventor
Satoko Fukagawa
聡子 深川
Taiji Kagawa
大治 加川
Yumiko Fujimoto
由美子 藤本
Masafumi Aoki
雅文 青木
Takatoshi Murase
孝利 村瀬
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Priority to JP2013035845A priority Critical patent/JP2014162761A/ja
Publication of JP2014162761A publication Critical patent/JP2014162761A/ja
Publication of JP2014162761A5 publication Critical patent/JP2014162761A5/ja
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2013035845A 2013-02-26 2013-02-26 血中ａｐｏＣＩ濃度低下剤 Pending JP2014162761A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2013035845A JP2014162761A (ja) 2013-02-26 2013-02-26 血中ａｐｏＣＩ濃度低下剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2013035845A JP2014162761A (ja) 2013-02-26 2013-02-26 血中ａｐｏＣＩ濃度低下剤

Publications (2)

Publication Number Publication Date
JP2014162761A true JP2014162761A (ja) 2014-09-08
JP2014162761A5 JP2014162761A5 (enExample) 2016-02-04

Family

ID=51613697

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013035845A Pending JP2014162761A (ja) 2013-02-26 2013-02-26 血中ａｐｏＣＩ濃度低下剤

Country Status (1)

Country Link
JP (1) JP2014162761A (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115813897A (zh) * 2021-09-17 2023-03-21 华东理工大学 克罗米通及其衍生物的抗衰老用途
CN117442598A (zh) * 2023-12-25 2024-01-26 天津嘉氏堂科技有限公司 硝酸酯类化合物在制备改善敏感肌表皮屏障产品中的应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10114665A (ja) * 1996-10-15 1998-05-06 Dokutaazu Kosumeteikusu:Kk 津液改善剤及びそれを含有する経口投与用組成物
JP2010019683A (ja) * 2008-07-10 2010-01-28 Biomarker Science:Kk 皮膚老化改善・進行遅延効果の評価方法及び評価用キット、並びに、物質のスクリーニング方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10114665A (ja) * 1996-10-15 1998-05-06 Dokutaazu Kosumeteikusu:Kk 津液改善剤及びそれを含有する経口投与用組成物
JP2010019683A (ja) * 2008-07-10 2010-01-28 Biomarker Science:Kk 皮膚老化改善・進行遅延効果の評価方法及び評価用キット、並びに、物質のスクリーニング方法

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115813897A (zh) * 2021-09-17 2023-03-21 华东理工大学 克罗米通及其衍生物的抗衰老用途
CN117442598A (zh) * 2023-12-25 2024-01-26 天津嘉氏堂科技有限公司 硝酸酯类化合物在制备改善敏感肌表皮屏障产品中的应用
CN117442598B (zh) * 2023-12-25 2024-03-12 天津嘉氏堂科技有限公司 硝酸酯类化合物在制备改善敏感肌表皮屏障产品中的应用

Similar Documents

Publication Publication Date Title
US20250302734A1 (en) Synthetic transdermal cannabidiol for the treatment of focal epilepsy in adults
JP5135568B2 (ja) 心臓血管疾患、関節炎、皮膚ガン、糖尿病、月経前症候群および経皮送達の予防および／または治療のためのオキアミおよび／または海洋生物の抽出物
JP5690261B2 (ja) β−ヒドロキシ−β−メチル酪酸および少なくとも１つのアミノ酸を含む組成物および使用法
JP7069490B2 (ja) ユウリコマ・ロンギフォリア抽出物並びに免疫系の増強及び／又は刺激におけるその使用
TWI280136B (en) Composition containing dipeptide of histidine and alanine for reducing uric acid
WO2018164221A1 (ja) 筋線維化抑制用組成物
JP7594581B2 (ja) Ｎｒ及び／又はｎｍｎとセサミン類とを含有する組成物
JP2019182881A (ja) 末梢神経障害の予防又は改善用組成物
EP3461479A1 (en) Nutraceutical and pharmaceutical compositions, and uses thereof for preserving cognitive functions
KR20160025808A (ko) 데커신 및/또는 데커시놀 안젤레이트 또는 데커신 및/또는 데커시놀 안젤레이트를 유효성분으로 하는 당귀추출물, 쌀눈 추출물, 무말랭이 추출물을 유효성분으로 포함하는 피로 또는 스트레스의 예방 또는 회복용 조성물
EP3621605B1 (en) Betaine for the prevention of obesity
TWI879956B (zh) 菸鹼醯胺腺嘌呤二核苷酸（ｎａｄ）濃度上升劑
JP2014162761A (ja) 血中ａｐｏＣＩ濃度低下剤
WO2019146735A1 (ja) 侵害受容性疼痛の予防又は改善用組成物
US7645795B2 (en) Method for treating amyotrophic lateral sclerosis
JP7523111B2 (ja) 老化細胞の排除促進剤
JP4645791B2 (ja) 高遊離脂肪酸血症の予防または改善用組成物
JP2021120358A (ja) 経口皮膚バリア機能向上剤
JP6547183B2 (ja) トリテルペンを有効成分として含有する変形性関節症の予防又は治療の為の組成物
WO2023223943A1 (ja) 血管内皮機能改善用組成物
JP2008044879A (ja) ラクトフェリンを含有する医薬組成物ならびに加工食品
WO2025075519A1 (en) Preparation and its application in atopic dermatitis in children
US20120064179A1 (en) Bicarbonate solution for bioavailable magnesium and uses thereof
KR20250088578A (ko) 베타-아드레날린 작용제 및 무스카린 길항제 조성물 및 사용 방법
JP2006213628A (ja) 抗ストレス剤

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20151214

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20151214

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160906

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20170307